APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medications for Chronic Pain Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medications for Chronic Pain Treatment Industry Growth and Trends Forecast to 2032

22 December 2025112 pages

Choose your research edition.

Industry ResearchMedications for Chronic Pain Treatment Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Chronic Pain Treatment Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medications for Chronic Pain Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Chronic Pain Treatment Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Chronic Pain Treatment Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

According to APO Research, the global Medications for Chronic Pain Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Medications for Chronic Pain Treatment market include YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD., Southwest Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., REYOUNG, Johnson and Johnson Services Inc., Novartis AG, Merck & Co., Jiangsu Hengrui Medicine Co,.Ltd and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medications for Chronic Pain Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medications for Chronic Pain Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medications for Chronic Pain Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medications for Chronic Pain Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Medications for Chronic Pain Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medications for Chronic Pain Treatment Market by Company

YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.

Southwest Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

REYOUNG

Johnson and Johnson Services Inc.

Novartis AG

Merck & Co.

Jiangsu Hengrui Medicine Co,.Ltd

Pfizer

GlaxoSmithKline plc.

BAYER

AstraZeneca plc.

Purdue Pharma L.P.

Endo International plc.

Depomed

Abbott Laboratories

Medications for Chronic Pain Treatment Segment by Type

Nonopioid

Opioids

Medications for Chronic Pain Treatment Segment by Application

Hospital

Pharmacy

Other

Medications for Chronic Pain Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Chronic Pain Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Chronic Pain Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Chronic Pain Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Medications for Chronic Pain Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Medications for Chronic Pain Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Medications for Chronic Pain Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Medications for Chronic Pain Treatment Market Share by Region (2021-2026) Table 4. Global Medications for Chronic Pain Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Medications for Chronic Pain Treatment Market Share by Region (2027-2032) Table 6. Global Medications for Chronic Pain Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Medications for Chronic Pain Treatment Market Size Share by Type (2021-2026) Table 9. Global Medications for Chronic Pain Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Medications for Chronic Pain Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Medications for Chronic Pain Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Medications for Chronic Pain Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Medications for Chronic Pain Treatment Market Size Share by Application (2021-2026) Table 24. Global Medications for Chronic Pain Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Medications for Chronic Pain Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Medications for Chronic Pain Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Medications for Chronic Pain Treatment Industry Trends Table 37. Medications for Chronic Pain Treatment Industry Drivers Table 38. Medications for Chronic Pain Treatment Industry Opportunities and Challenges Table 39. Medications for Chronic Pain Treatment Industry Restraints Table 40. Global Medications for Chronic Pain Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Medications for Chronic Pain Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Medications for Chronic Pain Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Medications for Chronic Pain Treatment Key Company Headquarters & Area Served Table 44. Global Medications for Chronic Pain Treatment Company, Product Type & Application Table 45. Global Medications for Chronic Pain Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Medications for Chronic Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Information Table 49. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview Table 50. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product Portfolio Table 52. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Development Table 53. Southwest Pharmaceutical Co., Ltd. Company Information Table 54. Southwest Pharmaceutical Co., Ltd. Business Overview Table 55. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product Portfolio Table 57. Southwest Pharmaceutical Co., Ltd. Recent Development Table 58. Teva Pharmaceutical Industries Ltd. Company Information Table 59. Teva Pharmaceutical Industries Ltd. Business Overview Table 60. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product Portfolio Table 62. Teva Pharmaceutical Industries Ltd. Recent Development Table 63. REYOUNG Company Information Table 64. REYOUNG Business Overview Table 65. REYOUNG Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. REYOUNG Medications for Chronic Pain Treatment Product Portfolio Table 67. REYOUNG Recent Development Table 68. Johnson and Johnson Services Inc. Company Information Table 69. Johnson and Johnson Services Inc. Business Overview Table 70. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product Portfolio Table 72. Johnson and Johnson Services Inc. Recent Development Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis AG Medications for Chronic Pain Treatment Product Portfolio Table 77. Novartis AG Recent Development Table 78. Merck & Co. Company Information Table 79. Merck & Co. Business Overview Table 80. Merck & Co. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Merck & Co. Medications for Chronic Pain Treatment Product Portfolio Table 82. Merck & Co. Recent Development Table 83. Jiangsu Hengrui Medicine Co,.Ltd Company Information Table 84. Jiangsu Hengrui Medicine Co,.Ltd Business Overview Table 85. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product Portfolio Table 87. Jiangsu Hengrui Medicine Co,.Ltd Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pfizer Medications for Chronic Pain Treatment Product Portfolio Table 92. Pfizer Recent Development Table 93. GlaxoSmithKline plc. Company Information Table 94. GlaxoSmithKline plc. Business Overview Table 95. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product Portfolio Table 97. GlaxoSmithKline plc. Recent Development Table 98. BAYER Company Information Table 99. BAYER Business Overview Table 100. BAYER Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. BAYER Medications for Chronic Pain Treatment Product Portfolio Table 102. BAYER Recent Development Table 103. AstraZeneca plc. Company Information Table 104. AstraZeneca plc. Business Overview Table 105. AstraZeneca plc. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. AstraZeneca plc. Medications for Chronic Pain Treatment Product Portfolio Table 107. AstraZeneca plc. Recent Development Table 108. Purdue Pharma L.P. Company Information Table 109. Purdue Pharma L.P. Business Overview Table 110. Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Purdue Pharma L.P. Medications for Chronic Pain Treatment Product Portfolio Table 112. Purdue Pharma L.P. Recent Development Table 113. Endo International plc. Company Information Table 114. Endo International plc. Business Overview Table 115. Endo International plc. Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Endo International plc. Medications for Chronic Pain Treatment Product Portfolio Table 117. Endo International plc. Recent Development Table 118. Depomed Company Information Table 119. Depomed Business Overview Table 120. Depomed Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Depomed Medications for Chronic Pain Treatment Product Portfolio Table 122. Depomed Recent Development Table 123. Abbott Laboratories Company Information Table 124. Abbott Laboratories Business Overview Table 125. Abbott Laboratories Medications for Chronic Pain Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Abbott Laboratories Medications for Chronic Pain Treatment Product Portfolio Table 127. Abbott Laboratories Recent Development Table 128. North America Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Medications for Chronic Pain Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Medications for Chronic Pain Treatment Market Share by Country (2021-2026) Table 131. North America Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Medications for Chronic Pain Treatment Market Share Forecast by Country (2027-2032) Table 133. Europe Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Medications for Chronic Pain Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Medications for Chronic Pain Treatment Market Share by Country (2021-2026) Table 136. Europe Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Medications for Chronic Pain Treatment Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Medications for Chronic Pain Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Medications for Chronic Pain Treatment Market Share by Country (2021-2026) Table 141. Asia-Pacific Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Medications for Chronic Pain Treatment Market Share Forecast by Country (2027-2032) Table 143. Latin America Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Medications for Chronic Pain Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Medications for Chronic Pain Treatment Market Share by Country (2021-2026) Table 146. Latin America Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Medications for Chronic Pain Treatment Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country (2021-2026) Table 151. Middle East & Africa Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Medications for Chronic Pain Treatment Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Medications for Chronic Pain Treatment Product Image Figure 3. Global Medications for Chronic Pain Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Medications for Chronic Pain Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Medications for Chronic Pain Treatment Market Share by Region (2021-2032) Figure 7. North America Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Nonopioid Image Figure 13. Global Nonopioid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Opioids Image Figure 15. Global Opioids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Medications for Chronic Pain Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Medications for Chronic Pain Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Medications for Chronic Pain Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Medications for Chronic Pain Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032) Figure 32. Europe Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032) Figure 34. Latin America Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Medications for Chronic Pain Treatment Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Medications for Chronic Pain Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Medications for Chronic Pain Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 41. Europe Medications for Chronic Pain Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Medications for Chronic Pain Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 44. Asia-Pacific Medications for Chronic Pain Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Medications for Chronic Pain Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 47. Latin America Medications for Chronic Pain Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Medications for Chronic Pain Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 50. Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Nonopioid
  • Opioids
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
  • Southwest Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • REYOUNG
  • Johnson and Johnson Services Inc.
  • Novartis AG
  • Merck & Co.
  • Jiangsu Hengrui Medicine Co,.Ltd
  • Pfizer
  • GlaxoSmithKline plc.
  • BAYER
  • AstraZeneca plc.
  • Purdue Pharma L.P.
  • Endo International plc.
  • Depomed
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Medications for Chronic Pain Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Medications for Chronic Pain Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Medications for Chronic Pain Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Medications for Chronic Pain Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Medications for Chronic Pain Treatment Market Size (2021-2032)
  8. 1.5.1 North America Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Medications for Chronic Pain Treatment Market Size Growth Rate (2021-2032)
2 Medications for Chronic Pain Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Nonopioid
  3. 2.1.2 Opioids
  4. 2.2 Global Medications for Chronic Pain Treatment Market Size by Type
  5. 2.2.1 Global Medications for Chronic Pain Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Medications for Chronic Pain Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Medications for Chronic Pain Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Medications for Chronic Pain Treatment Market Size by Regions
  9. 2.3.1 North America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Type (2021-2026)
3 Medications for Chronic Pain Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Medications for Chronic Pain Treatment Market Size by Application
  6. 3.2.1 Global Medications for Chronic Pain Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Medications for Chronic Pain Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Medications for Chronic Pain Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Medications for Chronic Pain Treatment Market Size by Regions
  10. 3.3.1 North America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Medications for Chronic Pain Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Medications for Chronic Pain Treatment Industry Trends
  2. 4.2 Medications for Chronic Pain Treatment Industry Drivers
  3. 4.3 Medications for Chronic Pain Treatment Industry Opportunities and Challenges
  4. 4.4 Medications for Chronic Pain Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Medications for Chronic Pain Treatment Revenue (2021-2026)
  2. 5.2 Global Medications for Chronic Pain Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Medications for Chronic Pain Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Medications for Chronic Pain Treatment Company, Product Type & Application
  5. 5.5 Global Medications for Chronic Pain Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Medications for Chronic Pain Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Medications for Chronic Pain Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Medications for Chronic Pain Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
  2. 6.1.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Information
  3. 6.1.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
  4. 6.1.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product Portfolio
  6. 6.1.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Developments
  7. 6.2 Southwest Pharmaceutical Co., Ltd.
  8. 6.2.1 Southwest Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product Portfolio
  12. 6.2.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Teva Pharmaceutical Industries Ltd.
  14. 6.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 6.4 REYOUNG
  20. 6.4.1 REYOUNG Company Information
  21. 6.4.2 REYOUNG Business Overview
  22. 6.4.3 REYOUNG Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 REYOUNG Medications for Chronic Pain Treatment Product Portfolio
  24. 6.4.5 REYOUNG Recent Developments
  25. 6.5 Johnson and Johnson Services Inc.
  26. 6.5.1 Johnson and Johnson Services Inc. Company Information
  27. 6.5.2 Johnson and Johnson Services Inc. Business Overview
  28. 6.5.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product Portfolio
  30. 6.5.5 Johnson and Johnson Services Inc. Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Medications for Chronic Pain Treatment Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Merck & Co. Medications for Chronic Pain Treatment Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Jiangsu Hengrui Medicine Co,.Ltd
  44. 6.8.1 Jiangsu Hengrui Medicine Co,.Ltd Company Information
  45. 6.8.2 Jiangsu Hengrui Medicine Co,.Ltd Business Overview
  46. 6.8.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product Portfolio
  48. 6.8.5 Jiangsu Hengrui Medicine Co,.Ltd Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Medications for Chronic Pain Treatment Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 GlaxoSmithKline plc.
  56. 6.10.1 GlaxoSmithKline plc. Company Information
  57. 6.10.2 GlaxoSmithKline plc. Business Overview
  58. 6.10.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product Portfolio
  60. 6.10.5 GlaxoSmithKline plc. Recent Developments
  61. 6.11 BAYER
  62. 6.11.1 BAYER Company Information
  63. 6.11.2 BAYER Business Overview
  64. 6.11.3 BAYER Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 BAYER Medications for Chronic Pain Treatment Product Portfolio
  66. 6.11.5 BAYER Recent Developments
  67. 6.12 AstraZeneca plc.
  68. 6.12.1 AstraZeneca plc. Company Information
  69. 6.12.2 AstraZeneca plc. Business Overview
  70. 6.12.3 AstraZeneca plc. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 AstraZeneca plc. Medications for Chronic Pain Treatment Product Portfolio
  72. 6.12.5 AstraZeneca plc. Recent Developments
  73. 6.13 Purdue Pharma L.P.
  74. 6.13.1 Purdue Pharma L.P. Company Information
  75. 6.13.2 Purdue Pharma L.P. Business Overview
  76. 6.13.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Purdue Pharma L.P. Medications for Chronic Pain Treatment Product Portfolio
  78. 6.13.5 Purdue Pharma L.P. Recent Developments
  79. 6.14 Endo International plc.
  80. 6.14.1 Endo International plc. Company Information
  81. 6.14.2 Endo International plc. Business Overview
  82. 6.14.3 Endo International plc. Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Endo International plc. Medications for Chronic Pain Treatment Product Portfolio
  84. 6.14.5 Endo International plc. Recent Developments
  85. 6.15 Depomed
  86. 6.15.1 Depomed Company Information
  87. 6.15.2 Depomed Business Overview
  88. 6.15.3 Depomed Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Depomed Medications for Chronic Pain Treatment Product Portfolio
  90. 6.15.5 Depomed Recent Developments
  91. 6.16 Abbott Laboratories
  92. 6.16.1 Abbott Laboratories Company Information
  93. 6.16.2 Abbott Laboratories Business Overview
  94. 6.16.3 Abbott Laboratories Medications for Chronic Pain Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Abbott Laboratories Medications for Chronic Pain Treatment Product Portfolio
  96. 6.16.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Medications for Chronic Pain Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst